Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

epstein barr virus reactivation may play a role in long covid and severe covid 19 cases

Sumary of Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases:

  • Two recently published studies available on the National Institutes of Health (NIH) website indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases.
  • This study can be viewed on the NIH website here: https://www.
  • gov/pmc/articles/PMC8233978/ We ran Epstein-Barr virus serological tests on COVID-19 patients at least 90 days after testing positive for SARS-CoV-2 infection, comparing EBV reactivation rates of those with long COVID symptoms to those who never experienced long COVID symptoms.
  • We found over 73% of COVID-19 patients who were experiencing long Covid symptoms were also positive for EBV reactivation.
  • Gold, Lead Study Author, World Organization Another group of researchers, Chen et al.
  • (2021), found EBV reactivation may also be associated with COVID-19 severity.
  • Related StoriesThe Pathogens study found that nearly one-third of 185 people surveyed who had tested positive for COVID-19 ended up with long haul symptoms, even some who were initially asymptomatic.
  • This percentage of long term sequelae after COVID-19 infection was similar to the percentage found in a separate study Sequelae in Adults at 6 Months After COVID-19 Infection published in JAMA Network Open.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.